Show source-provided references
1. Extra Cellular Matrix Remodeling: An Adjunctive Target for Spinal Cord Injury and Intervertebral Disc Degeneration
10.14245/ns.2244366.183 ↗2. Painful intervertebral disc degeneration and inflammation: From laboratory evidence to clinical interventions
10.1038/s41413-020-00125-x ↗3. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: A systematic analysis for the Global Burden of Disease Study 2019
10.1016/S0140-6736(20)32340-0 ↗5. Intervertebral Disc Degeneration: Biomaterials and Tissue Engineering Strategies toward Precision Medicine
10.1002/adhm.202102530 ↗6. Roh, E.J., Darai, A., Kyung, J., Choi, H., Kwon, S., Bhujel, B., Kim, K., and Han, I. (2021). Genetic therapy for intervertebral disc degeneration. Int. J. Mol. Sci., 22.
10.3390/ijms22041579 ↗9. The role of structure and function changes of sensory nervous system in intervertebral disc-related low back pain
10.1016/j.joca.2020.09.002 ↗10. The Beneficial Effect of Early Surgical Decompression for Acute Spinal Cord Injury: Time Is Spine
10.14245/ns.2142256.128 ↗11. A Comparison of Mortality and Morbidity between Complex and Degenerative Spine Surgery in Prospectively Collected Data from 2280 Procedures
10.14245/ns.2040628.314 ↗14. Actions of Prostaglandins on Human Nucleus Pulposus Metabolism Inferred by Cyclooxygenase 2 Inhibition of Cytokine Activated Cells
10.14245/ns.2040050.025 ↗15. Cyclooxygenase-2 deficiency causes delayed ossification of lumbar vertebral endplates
16. The Upregulation of COX2 in Human Degenerated Nucleus Pulposus: The Association of Inflammation with Intervertebral Disc Degeneration
10.1155/2021/2933199 ↗17. Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei
10.1002/cyto.10026 ↗18. Cyclooxygenase-2 is critical for the propagation of beta-amyloid protein and reducing the glycosylation of tau in Alzheimer’s disease
10.1038/s41423-019-0294-1 ↗19. Cyclooxygenase-2 contributes to oxidopamine-mediated neuronal inflammation and injury via the prostaglandin E2 receptor EP2 subtype
10.1038/s41598-017-09528-z ↗20. Inhibition of cyclooxygenase-2 by NS398 attenuates noise-induced hearing loss in mice
10.1038/srep22573 ↗22. Follistatin-like 1 attenuation suppresses intervertebral disc degeneration in mice through interacting with TNF-α and Smad signaling pathway
10.1155/2021/6640751 ↗25. Choi, U.Y., Joshi, H.P., Payne, S., Kim, K.T., Kyung, J.W., Choi, H., Cooke, M.J., Kwon, S.Y., Roh, E.J., and Sohn, S. (2020). An Injectable Hyaluronan-Methylcellulose (HAMC) Hydrogel Combined with Wharton’s Jelly-Derived Mesenchymal Stromal Cells (WJ-MSCs) Promotes Degenerative Disc Repair. Int. J. Mol. Sci., 21.
10.3390/ijms21197391 ↗26. A selective inhibition of c-Fos/activator protein-1 as a potential therapeutic target for intervertebral disc degeneration and associated pain
10.1038/s41598-017-17289-y ↗27. Quantitative MRI correlates with histological grade in a percutaneous needle injury mouse model of disc degeneration
10.1002/jor.24028 ↗28. An off–on Cox-2-specific fluorescent probe: Targeting the golgi apparatus of cancer cells
10.1021/ja4056905 ↗29. Highly sensitive naphthalene-based two-photon fluorescent probe for in situ real-time bioimaging of ultratrace cyclooxygenase-2 in living biosystems
10.1021/ac501944y ↗30. A Nile blue based infrared fluorescent probe: Imaging tumors that over-express cyclooxygenase-2
10.1039/C4CC08915D ↗32. Development of two-photon fluorescence probe for detecting cyclooxygenase-2 level in human colorectal cancer tissue
10.1016/j.snb.2020.129329 ↗34. Biochemically based design of cyclooxygenase-2 (COX-2) inhibitors: Facile conversion of nonsteroidal antiinflammatory drugs to potent and highly selective COX-2 inhibitors
10.1073/pnas.97.2.925 ↗35. The 2′-trifluoromethyl analogue of indomethacin is a potent and selective COX-2 inhibitor
10.1021/ml400066a ↗36. Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations
10.1038/s41467-022-29606-9 ↗